X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.globenewswire.com/news-release/2023/07/03/2698433/28908/en/Tonix-Pharmaceuticals-Completes-Acquisition-of-Two-FDA-Approved-Marketed-Migraine-Products.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213998
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-gets-usfda-nod-for-migraine-drug/articleshow/81288088.cms
https://www.moneycontrol.com/news/business/cipla-gets-usfda-nod-for-migraine-drug-6592371.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214209
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213465
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213650
https://www.prnewswire.com/news-releases/nuvo-pharmaceuticals-announces-health-canada-approves-suvexx-for-the-acute-treatment-of-migraine-301013063.html
https://www.prnewswire.com/news-releases/upsher-smith-laboratories-launches-tosymra-sumatriptan-nasal-spray-for-the-acute-treatment-of-migraine-in-adults-300929615.html
https://www.biospace.com/article/releases/currax-pharmaceuticals-llc-announces-first-acquisition-acquires-north-american-rights-to-onzetra-xsail-/?s=79
https://www.business-standard.com/article/pti-stories/dr-reddy-s-to-sell-2-neurology-branded-products-to-upsher-smith-labs-for-over-usd-110-mn-119061400240_1.html
https://health.economictimes.indiatimes.com/news/pharma/strides-subsidiary-inks-pact-with-suda-pharmaceuticals-for-migraine-drug/66553753
https://health.economictimes.indiatimes.com/news/pharma/strides-subsidiary-inks-pact-with-suda-pharmaceuticals-for-migraine-drug/66553753
https://www.biospectrumasia.com/news/25/12042/strides-enters-into-partnership-with-suda-pharma-for-migraine-drug.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090872
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202803
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207457
https://www.fiercepharma.com/marketing/pernix-lays-off-another-41-sales-staffers-as-treximet-generics-loom
http://www.prnewswire.com/news-releases/avanir-pharmaceuticals-to-present-data-on-nuedexta-and-onzetra-xsail-at-american-academy-of-neurology-aan-2017-annual-meeting-300441634.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/how-top-indian-drug-makers-like-sun-pharma-glenmark-are-building-a-brands-business-in-the-us/articleshow/56382828.cms
https://consumerist.com/2016/06/13/teva-pharmaceutical-pulling-migraine-patch-after-users-reported-burns-scars/
http://www.fiercepharma.com/pharma/teva-migraine-patch-zecuity-under-fda-safety-review
http://www.pharma-excipients.ch/2016/04/18/formulation-and-evaluation-of-gastro-retentive-drug-delivery-system-using-fenugreek-gum-as-novel-matrixing-agent/
https://www.pharmacompass.com/pdf/news/lannetts-generic-sumatriptan-approved-in-us-to-treat-migraine-headaches-1456221271.pdf
http://www.business-standard.com/article/companies/fda-approvals-to-boost-dr-reddy-s-prospects-in-us-nomura-116020300203_1.html
https://www.pharmacompass.com/pdf/news/dr-reddys-zembrace-symtouch-sumatriptan-approved-in-us-for-migraine-1454147412.pdf
https://www.pharmacompass.com/pdf/news/avanir-pharmas-onzetra-xsail-sumatriptan-approved-in-us-for-treatment-of-migraine-headaches-1454147230.pdf
http://www.pernixtx.com/news/fda-approves-treximet-sumatriptan-and-naproxen-sodium-for-use-in-pediatric-patients/
http://www.fiercepharma.com/story/pernix-figures-1-1-1-equals-more-three-new-zohydro-salesforce/2015-03-18
http://www.pernixtx.com/news/pernix-therapeutics-announces-fda-acceptance-with-priority-review-of-its-treximet-snda-for-use-in-adolescent-patients/
Market Place
Share 
